The once-daily cream can be used anywhere on the body and ...
40 percent of children achieved complete skin clearance at week 16 ...
It is the first topical JAK inhibitor approved in the U.S. ...
Benefits include sustained disease remission, reductions in itch, lower oral corticosteroids ...
The monoclonal antibody is a self-administered injection for prophylactic use to ...
Zevaskyn is the first and only autologous cell-based gene therapy for ...